133 related articles for article (PubMed ID: 31056594)
1. THE METABOLOMICS SIGNATURE ASSOCIATED WITH RESPONSIVENESS TO STEROID THERAPY IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS: A PILOT STUDY.
Chashmniam S; Kalantari S; Nafar M; Boroumandnia N
Rev Invest Clin; 2019; 71(2):106-115. PubMed ID: 31056594
[TBL] [Abstract][Full Text] [Related]
2. Steroid resistant focal segmental glomerulosclerosis: effect of arterial hyalinosis on outcome: single center study.
Soliman AR; Maamoun H; Soliman H; Ahmed RM
Rom J Intern Med; 2021 Jun; 59(2):127-133. PubMed ID: 33565308
[No Abstract] [Full Text] [Related]
3. Glomerular Transcriptome Profiles in Focal Glomerulosclerosis: New Genes and Pathways for Steroid Resistance.
Tong J; Jin Y; Weng Q; Yu S; Jafar Hussain HM; Ren H; Xu J; Zhang W; Li X; Wang W; Xie J; Chen N
Am J Nephrol; 2020; 51(6):442-452. PubMed ID: 32348995
[TBL] [Abstract][Full Text] [Related]
4. Predictive urinary biomarkers for steroid-resistant and steroid-sensitive focal segmental glomerulosclerosis using high resolution mass spectrometry and multivariate statistical analysis.
Kalantari S; Nafar M; Rutishauser D; Samavat S; Rezaei-Tavirani M; Yang H; Zubarev RA
BMC Nephrol; 2014 Sep; 15():141. PubMed ID: 25182141
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
[TBL] [Abstract][Full Text] [Related]
6. Duration of optimal therapy for idiopathic focal segmental glomerulosclerosis.
Pokhariyal S; Gulati S; Prasad N; Sharma RK; Singh U; Gupta RK; Mittal S; Mehta B
J Nephrol; 2003; 16(5):691-6. PubMed ID: 14733415
[TBL] [Abstract][Full Text] [Related]
7. Abatacept experience in steroid and rituximab-resistant focal segmental glomerulosclerosis.
Jayaraman VK; Thomas M
BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26887886
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study.
Senthil Nayagam L; Ganguli A; Rathi M; Kohli HS; Gupta KL; Joshi K; Sakhuja V; Jha V
Nephrol Dial Transplant; 2008 Jun; 23(6):1926-30. PubMed ID: 17989103
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis.
Alexopoulos E; Stangou M; Papagianni A; Pantzaki A; Papadimitriou M
Nephrol Dial Transplant; 2000 Sep; 15(9):1348-56. PubMed ID: 10978390
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.
Cattran DC; Appel GB; Hebert LA; Hunsicker LG; Pohl MA; Hoy WE; Maxwell DR; Kunis CL
Kidney Int; 1999 Dec; 56(6):2220-6. PubMed ID: 10594798
[TBL] [Abstract][Full Text] [Related]
11. Association of steroid and cyclosporin resistance in focal segmental glomerulosclerosis.
Shatat IF; Schoeneman M; Flynn JT; Woroniecki RP
Pediatr Nephrol; 2007 Jun; 22(6):834-9. PubMed ID: 17294224
[TBL] [Abstract][Full Text] [Related]
12. Distinct urinary lipid profile in children with focal segmental glomerulosclerosis.
Erkan E; Zhao X; Setchell K; Devarajan P
Pediatr Nephrol; 2016 Apr; 31(4):581-8. PubMed ID: 26537928
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus therapy in adult-onset steroid-resistant nephrotic syndrome due to a focal segmental glomerulosclerosis single-center experience.
Ramachandran R; Kumar V; Rathi M; Nada R; Jha V; Gupta KL; Sakhuja V; Kohli HS
Nephrol Dial Transplant; 2014 Oct; 29(10):1918-24. PubMed ID: 24771498
[TBL] [Abstract][Full Text] [Related]
14. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
[TBL] [Abstract][Full Text] [Related]
15. Expression of synaptopodin and GLEPP1 as markers of steroid responsiveness in primary focal segmental glomerulosclerosis.
Hirakawa M; Tsuruya K; Yotsueda H; Tokumoto M; Ikeda H; Katafuchi R; Fujimi S; Hirakata H; Iida M
Life Sci; 2006 Jul; 79(8):757-63. PubMed ID: 16564554
[TBL] [Abstract][Full Text] [Related]
16.
Kalantari S; Nafar M; Samavat S; Parvin M; Nobakht M Gh BF; Barzi F
Magn Reson Chem; 2016 Oct; 54(10):821-826. PubMed ID: 27320161
[TBL] [Abstract][Full Text] [Related]
17. Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis.
Romick-Rosendale LE; Brunner HI; Bennett MR; Mina R; Nelson S; Petri M; Kiani A; Devarajan P; Kennedy MA
Arthritis Res Ther; 2011; 13(6):R199. PubMed ID: 22152586
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study.
Goumenos DS; Tsagalis G; El Nahas AM; Shortland JR; Davlouros P; Vlachojannis JG; Brown CB
Nephron Clin Pract; 2006; 104(2):c75-82. PubMed ID: 16785738
[TBL] [Abstract][Full Text] [Related]
19. Clinical and morphological predictors of renal outcome in adult patients with focal and segmental glomerulosclerosis (FSGS).
Shiiki H; Nishino T; Uyama H; Kimura T; Nishimoto K; Iwano M; Kanauchi M; Fujii Y; Dohi K
Clin Nephrol; 1996 Dec; 46(6):362-8. PubMed ID: 8982551
[TBL] [Abstract][Full Text] [Related]
20. Low-dose methylprednisolone pulse therapy in Chinese children with steroid resistant focal segmental glomerulosclerosis.
Chang JW; Yang LY; Wang HH
Pediatr Int; 2007 Jun; 49(3):349-54. PubMed ID: 17532834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
